What are the blood test indicators for breast cancer

Relevant statistics show that breast cancer ranks first among the malignant tumors in Chinese women, and the incidence is increasing. The "gene screening technology for high-risk breast cancer population" has been officially put into use at the molecular diagnosis platform of the National Cancer Clinical Medicine Research Center, and only 5 ml of blood is needed to predict the incidence of breast cancer.

"Genetic testing is a technology that detects and analyzes gene sequences through blood, other body fluids or tumor tissues." Experts said that genetic testing can now predict which diseases people are more likely to suffer from in the future, and help doctors understand which drugs are more sensitive and effective for patients, so as to prevent or optimize individualized treatment plans in advance, reduce the incidence rate and increase the early diagnosis rate and survival rate. In May 2013, American movie star Angelina Jolie chose to undergo a double breast mastectomy because she learned through genetic testing that the probability of developing breast cancer is about 87%. The "gene screening technology for high-risk groups of breast cancer" put into use this time is similar to the testing technology Angelina Jolie received. The person being tested only needs to draw 5 ml of peripheral blood to perform full exon gene mutation detection on 6 breast cancer susceptibility genes, and then evaluate the probability of gene mutation carriers suffering from breast cancer based on the mutation of breast cancer susceptibility genes.

As tumor prevention and treatment are becoming more and more personalized, by comprehensively analyzing the differences in molecular typing, pathological type and clinical stage of tumors, different patients are grouped in detail and targeted prevention and treatment strategies are adopted, which can maximize the improvement of clinical prognosis and quality of life of tumor patients. In recent years, sequencing technology and bioinformatics technology have been continuously developed, and their advantages in tumor diagnosis, treatment, prevention and rehabilitation have become increasingly prominent. In the future, it will bring two major changes to cancer patients: one is personalized targeted treatment; the other is prevention of possible diseases. In addition, the application of new technologies will greatly improve the level of comprehensive tumor prevention and treatment in my country and keep pace with international advanced technologies.

Further reading

Who needs breast cancer gene testing?

Do all women need to undergo a breast cancer gene test? The answer is of course no. However, if you meet any of the following three conditions, it indicates that you may be at high risk of breast cancer and can undergo relevant tests.

1. Those who have had breast cancer in the past, especially those who developed the disease before the age of 50 and have been cured.

2. Having two or more close relatives with breast cancer.

3. There is a known gene mutation in the family.

After the test results come out, doctors will intervene for different groups of people according to the risk model table. Those with "low risk" do not need special intervention; those with "medium risk" need close observation and increased frequency of examinations; those with "high risk" need close observation and can also reduce the risk of breast cancer through drug intervention.